Name | lofexidine |
---|---|
Synonyms |
MFCD00865915
2-{1-[(2,6-dichlorophenyl)oxy]ethyl}-4,5-dihydro-1H-imidazole 2-(a-(2,6-dichlorophenoxy)ethyl)2-imidazoline Lofexidinum [INN-Latin] Lofexidina 1H-Imidazole, 2-[1-(2,6-dichlorophenoxy)ethyl]-4,5-dihydro- Britlofex Lofexidine (±)-2-[1-(2,6-Dichlorophenoxy)ethyl]-2-imidazoline Lofexidinum Lofexidine [INN:BAN] Lofexidina [INN-Spanish] 2-[1-(2,6-dichlorophenoxy)ethyl]-2-imidazoline UNII:UI82K0T627 (-)-2-[1-(2,6-dichlorophenoxy)-ethyl]-1,3-diazacyclopent-2-ene 2-[1-(2,6-Dichlorophenoxy)ethyl]-4,5-dihydro-1H-imidazole rac-2-[1-(2,6-dichlorophenoxy)ethyl]-1,3-diazacyclopent-2-ene |
Description | Lofexidine is a selective α2-receptor agonist, commonly used to alleviate the physical symptoms of heroin and other types of opioid withdrawal[1][2]. |
---|---|
Related Catalog | |
Target |
α2-receptor[1][2]. |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 421.5±35.0 °C at 760 mmHg |
Melting Point | 215-225 °C |
Molecular Formula | C11H12Cl2N2O |
Molecular Weight | 259.132 |
Flash Point | 208.7±25.9 °C |
Exact Mass | 258.032654 |
PSA | 33.62000 |
LogP | 3.59 |
Vapour Pressure | 0.0±1.0 mmHg at 25°C |
Index of Refraction | 1.611 |
Storage condition | -20°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Safety Phrases | S24/25 |
---|---|
WGK Germany | 3 |